AMIKAKI LIMITED
Opportunity 71/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (79/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 102Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-02-28 | 2024-02-28 |
|---|---|---|
| Total assets | £1.53M | £1.10M |
| Current assets | £1.74M | £1.27M |
| Cash | £1.67M | — |
| Debtors | £72.0k | — |
| Net assets | £1.52M | £1.08M |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
Recent activity
Corporate timeline (22 events)Click to expand
- 2025-11-28📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2025-07-16📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2025-07-16📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2024-11-29📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-09-16📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2023-11-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-08-21📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2022-11-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-11-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-02-26📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-12-21📄change-person-director-company-with-change-dateofficers · CH01
- 2020-12-21📄change-person-director-company-with-change-dateofficers · CH01
- 2020-12-21📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2019-11-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-11-13📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2018-11-30📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-02-10📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2018-01-25➕KARRA, Efthymia, Dr appointeddirector
- 2018-01-22➕YOUSSEIF, Ahmed Kamal Eldin Shahin, Dr appointeddirector
- 2018-01-22➖COWAN, Graham Michael resigneddirector
- 2017-02-01🏢Company incorporatedAs AMIKAKI LIMITED
- 2017-02-01➕COWAN, Graham Michael appointeddirector
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
Succession & seller-readiness
Limited succession signal. Not a near-term off-market candidate.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Efthymia Karra Individual · British · DOB 04/1977 · age 49 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 16/07/2025 |
Dr Ahmed Kamal Eldin Shahin Yousseif Individual · British · DOB 05/1969 · age 57 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 25/01/2018 |
1 historic (ceased) PSC
- Dr Efthymia Karraceased 16/07/2025· 25-50% shares · 25-50% voting · board control · significant influence · firm interest
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · NW postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ALHAKEEM CLINICAL CENTRE LTD→ 13219060 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| ALI-ABDIHAKIM LTD→ 14156874 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ALISON HAINSWORTH LTD→ 17115749 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ALRAHMA COMMUNITY DEVELOPMENT→ 09796292 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| AMF MEDICS LTD→ 15236560 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AMIRA GIRGIS LIMITED→ 07585681 · est 2011 · no financials extracted | — | — | — | — | 15y | — | — |
| AMOJO LIMITED→ 07136752 · est 2010 · no financials extracted | — | — | — | — | 16y | — | — |
| AMORA O LTD→ 13843714 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| AMRAN SMILES LTD→ 14304984 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AMY SARA 1 LTD→ 16215516 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| AN ORTHOPAEDICS LTD→ 16241981 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ANAESTH SERVICE LTD→ 14400544 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 1 resigned)
Click a director name to see their full track record across all companies.